Product dossierBuilt from registrations, label text and platform-curated data
艾佰瑞交联胶原蛋白植入剂
艾佰瑞 is a Collagen product (Class III device), registered by 北京艾佰瑞生物技术有限公司. Linked registrations: China 国械注准20263131506. First approved in China on 2026-07-20 (国械注准20263131506). Data as of 2026-10-24.
- Regulatory classCollagen · Class III device
- Holder北京艾佰瑞生物技术有限公司
- JurisdictionsCN
- Updated2026-10-24 · v1
Registration and basics are public; findings and prices need an account
Registration and basics
Label facts by jurisdiction
What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A
No data yet
Registration timeline
- CN
国械注准20263131506 first approved
- CN
国械注准20263131506 change
首次获批(受理号 CQZ2501473;2026年07月21日医疗器械批准证明文件送达信息)
- CN
国械注准20263131506 change
延续或变更注册获批(受理号 CQD2602331;2026年08月04日医疗器械批准证明文件送达信息)
- CN
国械注准20263131506 change
官网变更:载明生产地址由:北京市昌平区科技园区双营西路79号院33号楼2层、B1层;载明生产地址变更为:北京市昌平区双营西路79号院33号楼2层、B1层
- CN
国械注准20263131506 valid until
First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.
Cross findings · Price observations
Recent changes
3- 国械注准20263131506: 延续或变更注册获批(受理号 CQD2602331;2026年08月04日医疗器械批准证明文件送达信息)2026-07-28
- 国械注准20263131506: 官网变更:载明生产地址由:北京市昌平区科技园区双营西路79号院33号楼2层、B1层;载明生产地址变更为:北京市昌平区双营西路79号院33号楼2层、B1层2026-07-28
- 国械注准20263131506: 首次获批(受理号 CQZ2501473;2026年07月21日医疗器械批准证明文件送达信息)2026-07-20